13th China Healthcare Summit

About

The summit provides a firsthand look at China's life sciences ecosystem, covering licensing to newcos and how China innovation has reshaped the global biopharma landscape.

The 13th China Healthcare Summit in Shanghai provides a direct window into the country's rapidly evolving life sciences ecosystem. Industry leaders gather here to navigate the full value chain—from licensing deals and strategic partnerships to the formation of newcos. Attendees gain sharp insights into how China's innovation has fundamentally reshaped the global biopharma landscape, driving new drug discovery and development models. Sessions dissect regulatory shifts, capital flows, and market access strategies that define today's healthcare sector. Whether you're tracking out-licensing trends, evaluating clinical-stage assets, or exploring collaborative R&D, this summit delivers the on-the-ground intelligence needed to compete in Asia's most dynamic pharmaceutical market. The event consistently draws decision-makers from biotech, pharma, and investment firms serious about understanding China's role in the next wave of therapeutic breakthroughs.